A mouse model for nonalcoholic steatohepatitis

Journal of Nutritional Biochemistry

Volumn 22, Issue 10, 2011, Pages 979-984

  Sundaresan, Sinju ^a   Vijayagopal, Parakat ^a   Mills, Nathaniel ^a   Imrhan, Vicky ^a   Prasad, Chandan ^a  

^a TEXAS WOMAN'S UNIVERSITY   (United States)

Author keywords

Fibrosis; Insulin resistance; NASH

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHEMOKINE; CHOLESTEROL; CHOLINE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; METHIONINE; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; RESISTIN; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT INTAKE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEPATITIS; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLEPTINEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID LIVER LEVEL; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER WEIGHT; LOW FAT DIET; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANIMALS; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FATTY LIVER; HEPATOCYTES; LIVER; MICE; MICE, INBRED C57BL;

ANIMALIA; MUS;

EID: 80053099430     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.08.011     Document Type: Article

References (29)

1. Ludwig J., Viggiano T.R., McGill D.B., Ott B.J. Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin 1980, 55:434-438.
2. Brunt E.M. Pathology of nonalcoholic steatohepatitis. Hepatol Res 2005, 33:68-71.
3. Deng Q.G., She H., Cheng J.H., French S.W., Koop D.R., Xiong S., et al. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 2005, 42(4):905-914.
4. Anstee Q.M., Goldin R.D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006, 87(1):1-16.
5. Diehl A.M. Lessons from animal models of NASH. Hepatol Res 2005, 33:138-144.
6. Weltman M.D., Farrell G.C., Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996, 111:1645-1653.
7. Leclercq I.A., Farrell G.C., Field J.C., Bell D.R., Gonzalez F.J., Robertson G.R. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000, 105:1067-1075.
8. Collins S., Martin T.L., Surwit R.S., Robidoux J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse; physiological and molecular characteristics. Physiol Behav 2002, 81:243-248.
9. Cong W.N., Tao R.Y., Tian J.Y., Liu G.T., Ye F. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance. Life Sci 2008, 82:983-990.
10. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
11. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11:81-128.
12. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
13. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
14. George J., Pera N., Phung N., Leclercq I., Yun Hou J., Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 2003, 39:756-764.
15. London R.M., George J. Pathogenesis of NASH: animal models. Clin Liver Dis 2007, 11:55-74.
16. Jansen P.L.M. Nonalcoholic steatohepatitis. J Med 2004, 62:217-224.
17. Powell E.E., Cooksley W.G.E., Hanson R., Searle J., Halliday J.W., Powell L.W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990, 11:74-80.
18. Sanyal A.J., Campbell S.C., Mirshahi F., Rizzo W.B., Contos M.J., Sterling R.K., et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001, 120:1183-1192.
19. Chitturi S., Abeygunasekhara S., Farrell G.C., Holmes-Walker J., Hui J.M., Fung C., et al. Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35:373-379.
20. Marceau P., Biron S., Hould F.S., Marceau S., Simard S., Thung S.N., et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999, 84:1513-1517.
21. Marchesini G., Brizi M., Morselli-Labate A.M., Bianchi G., Bugianesi E., McCullough A.J., et al. Association of non-alcoholic fatty liver disease with insulin resistance. Am J Med 1999, 107:450-455.
22. Rinella M.E., Green R.M. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 2004, 40:47-51.
23. Hui J.M., Hodge A., Farrell G.C., Kench J.G., Kriketos A., George J. Beyond insulin resistance in NASH:TNF-alpha or adiponectin?. Hepatology 2004, 40:46-54.
24. Kaser S., Moschen A., Cayon A., Kaser A., Crespo J., Pons-Romero F., et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 2005, 54:117-121.
25. Tilg H., Diehl A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000, 343:1467-1476.
26. Yoneda M., Mawatari H., Fujita K., Iida H., Yonemitsu K., Kato S., et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol 2007, 42(7):573-582.
27. Uygun A., Kadayifci A., Yesilova Z., Erdil A., Yaman H., Saka M., et al. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2000, 95(12):3584-3589.
28. Oberhammer F.A., Pavelka M., Sharma S., Tiefenbacher R., Purchio A.F., Bursch W, Schulte-Hermann R Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-β1. Proc Natl Acad Sci. USA 1992, 9:5408-5412.
29. Hasegawa T., Yoneda M., Nakamura K., Makino I., Terano A. Plasma transforming growth factor-b1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 2001, 15:1667-1672.